Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts. (2020)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2020.00079
PubMed Identifier: 32117242
Publication URI: http://europepmc.org/abstract/MED/32117242
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in immunology
ISSN: 1664-3224